Multistage Designs for Vaccine Safety Studies
- 1 August 2006
- journal article
- research article
- Published by Taylor & Francis Ltd in Journal of Biopharmaceutical Statistics
- Vol. 16 (4), 539-553
- https://doi.org/10.1080/10543400600721554
Abstract
In a placebo-controlled vaccine safety trial, the primary interest is to demonstrate that the vaccine is sufficiently safe, rejecting the null hypothesis that the relative risk of an adverse event attributable to the vaccine is above a prespecified value, greater than one. We develop sequential as well as multistage designs for such trials where the interim analyses are conducted not after a given number of subjects but rather after a given number of events observed. We show that these designs achieve significant improvement over single-stage conditional test in terms of both the required number of events to be observed and the required number of subjects to be enrolled.Keywords
This publication has 5 references indexed in Scilit:
- Statistical approaches to establishing vaccine safetyStatistics in Medicine, 2002
- Exact sequential tests for single samples of discrete responses using spending functionsStatistics in Medicine, 2000
- Formal approaches to safety monitoring of clinical trials in life-threatening conditionsStatistics in Medicine, 2000
- Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.Biometrics, 1998
- A Class of Sequential Conditional Probability Ratio TestsJournal of the American Statistical Association, 1995